Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXL01116	依托度酸	etodolac	Active ingredient	Chemical Drugs(4)	New Drug Application	2001-03-02	北京圣德莱宝制药有限公司	Stada Pharmaceuticals (Beijing) Ltd	Certificate Issued	2003-08-18	view
CXL01117	依托度酸胶囊	etodolac	Capsule	Chemical Drugs(4)	New Drug Application	2001-03-02	北京圣德莱宝制药有限公司	Stada Pharmaceuticals (Beijing) Ltd	Certificate Issued	2003-08-18	view
CZb01071	清热解毒糖浆		Oral solution	Chinese Herbal Medicine(4)	Supplementary Application	2002-02-26	北京圣德制药有限公司	Stada Pharmaceuticals (Beijing) Ltd	Certificate Issued	2003-05-09	view
CXHS0500618	利拉萘酯乳膏	liranaftate	Cream	Chemical Drugs(3.1)	New Drug Application	2005-04-01	北京圣德莱宝制药有限公司	Stada Pharmaceuticals (Beijing) Ltd	Certificate Issued	2006-01-18	view
CYHS0504879	异丙托溴铵气雾剂	ipratropium bromide	Aerosol	Chemical Drugs(6)	Generic Drug	2005-08-09	北京圣德莱宝制药有限公司	Stada Pharmaceuticals (Beijing) Ltd	Certificate Issued	2005-12-31	view
CXHL1401595	恩替卡韦口服溶液	entecavir	Oral solution	Chemical Drugs(5)	New Drug Application	2015-02-13	史达德药业（北京）有限公司	Stada Pharmaceuticals (Beijing) Ltd	Certificate Issued	2016-10-18	view
CYHS1900151	恩替卡韦口服溶液	entecavir	Oral solution	Chemical Drugs(3)	Generic Drug	2019-03-11	史达德药业（北京）有限公司	Stada Pharmaceuticals (Beijing) Ltd	In Review	2019-03-08	view